Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1980 1
1981 1
1985 1
1989 1
1991 1
1993 5
1994 3
1995 2
1997 1
1998 4
1999 2
2000 4
2001 6
2002 7
2003 9
2004 7
2005 13
2006 21
2007 25
2008 17
2009 17
2010 13
2011 25
2012 22
2013 26
2014 24
2015 35
2016 27
2017 39
2018 44
2019 37
2020 44
2021 65
2022 36
2023 42
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

524 results

Results by year

Filters applied: . Clear all
Page 1
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers.
Lowery FJ, Krishna S, Yossef R, Parikh NB, Chatani PD, Zacharakis N, Parkhurst MR, Levin N, Sindiri S, Sachs A, Hitscherich KJ, Yu Z, Vale NR, Lu YC, Zheng Z, Jia L, Gartner JJ, Hill VK, Copeland AR, Nah SK, Masi RV, Gasmi B, Kivitz S, Paria BC, Florentin M, Kim SP, Hanada KI, Li YF, Ngo LT, Ray S, Shindorf ML, Levi ST, Shepherd R, Toy C, Parikh AY, Prickett TD, Kelly MC, Beyer R, Goff SL, Yang JC, Robbins PF, Rosenberg SA. Lowery FJ, et al. Among authors: nah sk. Science. 2022 Feb 25;375(6583):877-884. doi: 10.1126/science.abl5447. Epub 2022 Feb 3. Science. 2022. PMID: 35113651 Free PMC article.
Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers.
Yossef R, Krishna S, Sindiri S, Lowery FJ, Copeland AR, Gartner JJ, Parkhurst MR, Parikh NB, Hitscherich KJ, Levi ST, Chatani PD, Zacharakis N, Levin N, Vale NR, Nah SK, Dinerman A, Hill VK, Ray S, Bera A, Levy L, Jia L, Kelly MC, Goff SL, Robbins PF, Rosenberg SA. Yossef R, et al. Among authors: nah sk. Cancer Cell. 2023 Dec 11;41(12):2154-2165.e5. doi: 10.1016/j.ccell.2023.11.005. Epub 2023 Nov 30. Cancer Cell. 2023. PMID: 38039963
Animal lectins: potential receptors for ginseng polysaccharides.
Loh SH, Park JY, Cho EH, Nah SY, Kang YS. Loh SH, et al. Among authors: nah sy. J Ginseng Res. 2017 Jan;41(1):1-9. doi: 10.1016/j.jgr.2015.12.006. Epub 2015 Dec 17. J Ginseng Res. 2017. PMID: 28123316 Free PMC article. Review.
Panax ginseng as an adjuvant treatment for Alzheimer's disease.
Kim HJ, Jung SW, Kim SY, Cho IH, Kim HC, Rhim H, Kim M, Nah SY. Kim HJ, et al. Among authors: nah sy. J Ginseng Res. 2018 Oct;42(4):401-411. doi: 10.1016/j.jgr.2017.12.008. Epub 2018 Jan 12. J Ginseng Res. 2018. PMID: 30337800 Free PMC article. Review.
Protective Potential of Ginkgo biloba Against an ADHD-like Condition.
Sharma G, Sharma N, Nguyen BT, Jeong JH, Nah SY, Yoneda Y, Shin EJ, Kim HC. Sharma G, et al. Among authors: nah sy. Curr Mol Pharmacol. 2021;14(2):200-209. doi: 10.2174/1874467213666200424152454. Curr Mol Pharmacol. 2021. PMID: 32329705 Review.
Can Panax ginseng help control cytokine storm in COVID-19?
Choi JH, Lee YH, Kwon TW, Ko SG, Nah SY, Cho IH. Choi JH, et al. Among authors: nah sy. J Ginseng Res. 2022 May;46(3):337-347. doi: 10.1016/j.jgr.2022.02.006. Epub 2022 Feb 25. J Ginseng Res. 2022. PMID: 35233163 Free PMC article. Review.
524 results